Global search | Diasorin

Financial Data

Investors

Press releases

2008 Financial calendar

29/01/08 - 1:00

Financial Data

Investors

Press releases

2008 Financial calendar update

21/04/08 - 2:00

Financial Data

Investors

Press releases

2009 Financial calendar

28/01/09 - 1:00

Financial Data

Investors

Press releases

2009 Financial calendar update

08/04/09 - 2:00

Financial Data

Investors

Press releases

2009 Financial calendar update

08/06/09 - 2:00

Financial Data

Investors

Press releases

2009 Financial calendar update

08/10/09 - 2:00

Financial Data

Investors

Press releases

2010 Financial calendar

18/01/10 - 1:00

Financial Data

Investors

Press releases

2010 Financial calendar update

01/03/10 - 1:00

Financial Data

Investors

Press releases

2010 Financial calendar update

20/04/10 - 2:00

Financial Data

Investors

Press releases

2010 Financial calendar update

06/07/10 - 2:00

Financial Data

Investors

Press releases

2010 Financial calendar update

08/10/10 - 2:00

Financial Data

Investors

Press releases

2011 Financial calendar

22/12/10 - 1:00

Financial Data

Investors

Press releases

2011 Financial calendar

16/01/11 - 1:00

Financial Data

Investors

Press releases

2011 Financial calendar update

28/02/11 - 1:00

Financial Data

Investors

Press releases

2011 Financial calendar update

31/08/11 - 2:00

Financial Data

Investors

Press releases

2011 statutory financial statement approval

23/04/12 - 2:00

Financial Data

Investors

Press releases

2011-2015 Business Plan: a new business wave

17/10/11 - 2:00

Financial Data

Investors

Press releases

2012 Financial calendar

13/01/12 - 1:00

Financial Data

Investors

Press releases

2012 Financial calendar update

27/01/12 - 1:00

Financial Data

Investors

Events

2017 Corporate Events Annual Calendar

25/01/2017

Financial calendar

Past event

Newsroom

Events

2017 Corporate Events Annual Calendar

29/01/2018

Financial calendar

Past event

Newsroom

Events

2021 Annual Calendar of Corporate Events

27/01/2021

Financial calendar

Past event

Newsroom

Press releases

2021 Annual Calendar of Corporate Events

27/01/21 - 18:50

Other

Investors

Events

2022 annual Calendar of Corporate Events

01/01/2022

Financial calendar

Past event

Newsroom

Press releases

2022 Annual Calendar of Corporate Events

21/12/21 - 11:07

Other

Investors

Page

2022 Report

View page

Events

2023 Annual Calendar of Corporate Events

01/01/2023

Financial calendar

Past event

Newsroom

Press releases

2023 Annual Calendar of Corporate Events

01/12/22 - 18:30

Other

Investors

Events

2023 Investor Day: Diasorin 3.0

15/12/2023

virtual

Past event

Newsroom

Page

2023-2025 ESG Objectives

View page

Sustainability

Events

2024 Annual Calendar of Corporate Events

18/01/2024

Financial calendar

Past event

Newsroom

Press releases

2024 Annual Calendar of Corporate Events

18/01/24 - 12:30

Other

Investors

Events

2025 Annual Calendar of Corporate Events

17/12/2024

Financial calendar

Past event

Newsroom

Press releases

2025 Annual Calendar of Corporate Events

17/12/24 - 12:56

Investors

Events

20th Berenberg European Conference

07/12/2022

London

Past event

Newsroom

Events

39th Annual J.P. Morgan Healthcare Conference

11/01/2021

Past event

Newsroom

Events

3rd Kepler Cheuvreux Diagnostics Day

22/11/2022

Virtual

Past event

Newsroom

Events

43rd Annual J.P. Morgan Healthcare Conference

15/01/2025

San Francisco

Past event

Newsroom

Events

4th BNPP Exane DILS Conference

11/12/2024

virtual

Past event

Newsroom

Events

5th Kepler Cheuvreux Diagnostics Day

27/11/2024

virtual

Past event

Newsroom

Events

6th annual pan European Bank Of America Merril Lynch Medtech conference

19/05/2009

Past event

Newsroom

Presentation

9M 2016 Results Presentation

10/11/16

Investors

Events

9M 2017 Results: Conference call invitation

27/10/2017

Corporate event

Past event

Newsroom

Presentation

9M 2017 Results Presentation

09/11/17

Investors

Presentation

9M 2018 Results Presentation

07/11/18

Investors

Results

9M 2018 Results Presentation

Investors

Events

9M 2019 Results - Conference Call

14/10/2019

Corporate event

Past event

Newsroom

Presentation

9M 2019 Results Presentation

06/11/19

Investors

Results

9M 2019 Results Presentation

Investors

Events

9M 2020 Results - Conference Call

11/11/2020

Corporate event

Past event

Newsroom

Presentation

9M 2020 Results Presentation

11/11/20

Investors

Results

9M 2020 Results Presentation

Investors

Events

9M 2021 Results - Conference Call

11/11/2021

Corporate event

Past event

Newsroom

Presentation

9M 2021 Results Presentation

11/11/21

Investors

Results

9M 2021 Results Presentation

Investors

Events

9M 2022 Results - Conference Call

27/10/2022

Corporate event

Past event

Newsroom

Results

9M 2022 Results Presentation

Investors

Events

9M 2023 Results - Conference Call

03/11/2023

Corporate event

Past event

Newsroom

Results

9M 2023 Results Presentation

Investors

Presentation

9M 2023 Results Presentation

03/11/23

Investors

Results

9M 2024 Results Presentation

Investors

Events

9M'18 Results - Conference Call

30/10/2018

Corporate event

Past event

Newsroom

Press releases

A new Group website for DiaSorin: www.diasoringroup.com

06/03/19 - 8:45

Other

Investors

Page

Accessibility

View page

Legal information

Press releases

Acquisition of Biotrin

09/07/08 - 2:00

Acquisition / Partnership

Investors

Press releases

Acquisition of Focus Diagnostics' Molecular and Immunoassay Product Business

13/05/16 - 2:00

Acquisition / Partnership

Investors

Press releases

Acquisition of MUREX product line

10/03/10 - 1:00

Acquisition / Partnership

Investors

Press releases

Acquisition of MUREX product line

01/06/10 - 2:00

Acquisition / Partnership

Investors

Press releases

Administrative sanctions imposed by CONSOB in connection with the alleged breach to disclose obligations relating to inside information. Action for annulment.

05/06/23 - 21:58

Other

Investors

Press releases

Agreement in Japan with Advanced Life Science Institute

22/09/08 - 2:00

Acquisition / Partnership

Investors

Press releases

Agreement with Meridian Inc.

07/07/10 - 2:00

Acquisition / Partnership

Investors

Press releases

Agreement with Precision System Science Co., LTD

06/05/11 - 2:00

Acquisition / Partnership

Investors

Press releases

Agreement with Sonic Healthcare on Vitamin D

12/03/12 - 1:00

Acquisition / Partnership

Investors

Press releases

Aldosterone on LIAISON (available outside the US and Canada only)

29/01/13 - 1:00

Products Immunodiagnostic

Investors

Coverage

ALPHAVALUE

Investors

Top management

Amelia Parente

View page

About Diasorin

Image gallery

Amelia Parente

Download (high) Download (low)

Top Management

Newsroom

Presentation

Analyst Day 2012

10/10/12

Investors

Top management

Angelo Rago

View page

About Diasorin

Image gallery

Angelo Rago

Download (high) Download (low)

Top Management

Newsroom

Buy back program

Annex 3F - Treasury Shares buy back August 2024

03/09/24 - 14:00

About Diasorin

Buy back program

Annex 3F - Treasury shares buy back October 2024

04/11/24 - 13:00

About Diasorin

Buy back program

Annex 3F - Treasury Shares buy back September 2024

04/10/24 - 14:00

About Diasorin

Buy back program

Annex 3F (Buy back) - June 2016

04/07/16 - 14:00

About Diasorin

Buy back program

Annex 3F (Buy back) - May 2016

01/06/16 - 14:00

About Diasorin

Press releases

Annex 3F (treasury shares buy back)

24/04/18 - 14:00

Financial Data

Investors

Buy back program

Annex 3F (treasury shares buy back July 2018)

04/07/18 - 14:00

About Diasorin

Press releases

Annex 3F (treasury shares buy back July 2018)

03/07/18 - 18:30

Financial Data

Investors

Buy back program

Annex 3F (treasury shares buy back June 2018)

04/07/18 - 14:00

About Diasorin

Press releases

Annex 3F (treasury shares buy back June 2018)

03/07/18 - 18:30

Financial Data

Investors

Buy back program

Annex 3F (treasury shares buy back May 2018)

04/06/18 - 14:00

About Diasorin

Press releases

Annex 3F (treasury shares buy back May 2018)

04/06/18 - 13:15

Financial Data

Investors

Buy back program

Annex 3F (treasury shares buy back November 2020)

04/12/20 - 13:00

About Diasorin

Buy back program

Annex 3F (treasury shares buy-back)

24/04/18 - 14:00

About Diasorin

Page

Annual & Interim Reports

View page

Investors

Events

Annual Calendar of Corporate Events 2019

25/01/2019

Financial calendar

Past event

Newsroom

Events

Annual Calendar of Corporate Events 2020

15/01/2020

Financial calendar

Past event

Newsroom

Press releases

Annual Calendar of Corporate Events 2020

15/01/20 - 16:51

Other

Investors

Shareholders' meeting

Annual Financial Report 2013

23/04/14 - 14:00

About Diasorin

Shareholders' meeting

Annual Financial Report 2014

22/04/15 - 14:00

About Diasorin

Shareholders' meeting

Annual Financial Report 2015

28/04/16 - 14:00

About Diasorin

Shareholders' meeting

Annual Financial Report 2016

27/04/17 - 14:00

About Diasorin

Shareholders' meeting

Annual Financial Report 2017

23/04/18 - 14:00

About Diasorin

Shareholders' meeting

Annual Financial Report 2018

24/04/19 - 14:00

About Diasorin

Shareholders' meeting

Annual Financial Report as at December 31, 2021

16/03/22 - 13:00

About Diasorin

Annual and Interim Reports

Annual Financial Report as at December 31, 2023

17/04/24

Immunodiagnostics

Shareholders' meeting

Annual Financial Report as at December 31, 2023

16/04/24 - 14:00

About Diasorin

Annual and Interim Reports

Annual Financial Report at December 31, 2008

31/12/08

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2009

31/12/09

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2010

31/12/10

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2011

31/12/11

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2012

16/04/13

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2013

10/04/14

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2014

30/03/15

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2015

11/04/16

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2016

10/04/17

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2017

30/03/18

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2018

16/04/19

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2019

08/05/20

Investors

Shareholders' meeting

Annual Financial Report at December 31, 2019 (dividend dates update)

10/06/20 - 14:00

About Diasorin

Annual and Interim Reports

Annual Financial Report at December 31, 2020

01/04/21

Investors

Shareholders' meeting

Annual Financial Report at December 31, 2020

22/04/21 - 14:00

About Diasorin

Annual and Interim Reports

Annual Financial Report at December 31, 2021

21/04/22

Investors

Annual and Interim Reports

Annual Financial Report at December 31, 2022

28/04/23

Investors

Press releases

Annual General Meeting 2018

23/04/18 - 18:30

Financial Data

Investors

Information Documents

Annual information document DiaSorin S.p.A.

Information Documents

Annual information document DiaSorin S.p.A.

Information Documents

Annual information document DiaSorin S.p.A.

Information Documents

Annual information document DiaSorin S.p.A.

Information Documents

Annual information document DiaSorin S.p.A.

Shareholders' meeting

Annual information document DiaSorin S.p.A.

19/07/10 - 14:00

About Diasorin

Shareholders' meeting

Annual Information Document pursuant to Article 54 of the Regulations

28/04/11 - 14:00

About Diasorin

Events

Annual Report 2007 approval

19/03/2008

Financial calendar

Past event

Newsroom

Events

Annual Report 2007 approval

19/03/2008

Financial calendar

Past event

Newsroom

Events

Annual Report 2008 approval

18/03/2009

Financial calendar

Past event

Newsroom

Events

Annual Report 2009 approval

22/03/2010

Financial calendar

Past event

Newsroom

Events

Annual report 2010 approval

16/03/2011

Financial calendar

Past event

Newsroom

Events

Annual Report 2011 approval

09/03/2012

Financial calendar

Past event

Newsroom

Events

Annual Report 2011 approval - First call

23/04/2012

Financial calendar

Past event

Newsroom

Events

Annual Report 2011 approval - Second call

24/04/2012

Financial calendar

Past event

Newsroom

Shareholders' meeting

Annual report 2012

22/04/13 - 14:00

About Diasorin

Events

Annual report approval - First call

28/04/2011

Financial calendar

Past event

Newsroom

Events

Annual report approval - Second call

29/04/2011

Financial calendar

Past event

Newsroom

Press releases

Approval of statutory financial statements

27/04/10 - 2:00

Financial Data

Investors

Shareholders' meeting

Auditors’ Opinion – Consolidated Statements

23/04/12 - 14:00

About Diasorin

Shareholders' meeting

Auditors’ Opinion – Statutory Statements

23/04/12 - 14:00

About Diasorin

Annual and Interim Reports

Auditors' Opinion on H1'12 report

30/08/13

Investors

Shareholders' meeting

Auditors' Report - Consolidated Financial Statements

23/04/14 - 14:00

About Diasorin

Shareholders' meeting

Auditors' Report - Statutory Financial Statements

23/04/14 - 14:00

About Diasorin

Shareholders' meeting

Auditor's Report on the Consolidated Financial Statements

28/04/09 - 14:00

About Diasorin

Shareholders' meeting

Auditor's Report on the Financial Statements

28/04/09 - 14:00

About Diasorin

Image gallery

Automation

Download (high) Download (low)

Research laboratory

Newsroom

Coverage

BANCA AKROS

Investors

Events

Banca Akros - CEO Lunch Meeting

03/04/2023

Past event

Newsroom

Events

Banca Akros - ESN Conference

20/11/2024

Paris

Past event

Newsroom

Events

Banca Akros - ESN Conference

29/11/2023

Paris

Past event

Newsroom

Events

Banca Akros - ESN Conference

06/12/2022

Paris

Past event

Newsroom

Events

Banca Akros - Roadshow

26/09/2022

Madrid

Past event

Newsroom

Events

Banca Akros - Roadshow

27/09/2022

Lisbon

Past event

Newsroom

Events

Banca Akros - Roadshow

28/03/2023

London

Past event

Newsroom

Events

Banca Akros - Roadshow

08/02/2024

Copenhagen

Past event

Newsroom

Events

Banca Akros - Roadshow

07/02/2024

Helsinki

Past event

Newsroom

Coverage

BANCA IMI

Investors

Events

Banca IMI - Roadshow

30/03/2023

Paris

Past event

Newsroom

Events

Bank of America - Global Healthcare Conference 2021

15/09/2021

Past event

Newsroom

Coverage

Barclays

Investors

Coverage

Barclays

Investors

Events

Barclays - Reverse Roadshow

10/09/2024

Past event

Newsroom

Licensed technologies Application

Bead-Based Multiplexing vs. Electrochemiluminescence

View page

Luminex LTG

Events

Beremberg diagnostics day

03/06/2010

Past event

Newsroom

Events

Berenberg - Diagnostics Conference

15/05/2024

London

Past event

Newsroom

Events

Berenberg - Virtual Fireside Chat

29/10/2021

Past event

Newsroom

Events

Berenberg - Virtual Roadshow

11/01/2022

Past event

Newsroom

Events

Berenberg Conference USA

18/05/2021

Past event

Newsroom

Events

Berenberg Diagnostic Conference 2022

10/05/2022

Past event

Newsroom

Events

Berenberg Diagnostics Conference

11/05/2021

Past event

Newsroom

Events

Berenberg Diagnostics Conference 2023

11/05/2023

London

Past event

Newsroom

Events

Berenberg European Conference

02/12/2020

Past event

Newsroom

Events

BNP Paribas Exane - 2nd DILS CEO Conference

29/11/2022

Virtual

Past event

Newsroom

Events

BNP Paribas Exane - 4th MedTech Conference

29/03/2023

Virtual

Past event

Newsroom

Events

BNP Paribas Exane - Healthcare Conference

26/03/2024

Virtual

Past event

Newsroom

Shareholders' meeting

Board of Directors - Slate of candidates majority shareholders

28/04/16 - 14:00

About Diasorin

Events

Board of Directors: Annual Report and Consolidated Financial Statements 2009 Approval

22/03/2010

Financial calendar

Past event

Newsroom

Events

Board of Directors: H1'10 results approval

06/08/2010

Financial calendar

Past event

Newsroom

Events

Board of Directors: Q1'10 results approval

14/05/2010

Financial calendar

Past event

Newsroom

Shareholders' meeting

Board of Statutory Auditors - Slate of candidates majority shareholders

28/04/16 - 14:00

About Diasorin

Shareholders' meeting

Board of Statutory Auditors - Slate of candidates minority shareholders

28/04/16 - 14:00

About Diasorin

Coverage

BofA

Investors

Events

BofA - Fireside Chat

10/07/2024

virtual

Past event

Newsroom

Events

BofA Global Healthcare Conference

17/09/2020

Past event

Newsroom

Events

BofA Global Healthcare Conference 2022

14/09/2022

Past event

Newsroom

Events

BofA Global Healthcare Conference 2024

18/09/2024

London

Past event

Newsroom

Events

BofA Global Research C-Suite SMID Cap Conference 2022

13/01/2022

Past event

Newsroom

Page

Bond

View page

Investors

Events

Borsa Italiana - Industrial & Healthcare Day

14/09/2020

Past event

Newsroom

Events

Borsa Italiana - Italian Equity Conference London 2021 – Virtual Edition

13/01/2021

Past event

Newsroom

Events

Borsa Italiana | Industrial & Healthcare Day 2021

08/09/2021

Past event

Newsroom

Materiality issues

Business ethics, fight against corruption and anti-competitive behavior

View page

Sustainability

Page

Business Model

View page

About Diasorin

Page

Buy back program

View page

About Diasorin

Press releases

Buy-back plan

17/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

18/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

19/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

20/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

21/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

24/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

25/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

27/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

28/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

29/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

31/01/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

15/02/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

16/02/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

18/02/11 - 1:00

Financial Data

Investors

Press releases

Buy-back plan

04/10/11 - 2:00

Financial Data

Investors

Press releases

Buy-back plan

18/10/11 - 2:00

Financial Data

Investors

Press releases

Buy-back plan

25/10/11 - 2:00

Financial Data

Investors

Press releases

Buy-back plan

28/10/11 - 2:00

Financial Data

Investors

Press releases

Buy-back plan

19/11/11 - 1:00

Financial Data

Investors

Page

By Disease

View page

Molecular Diagnostics

Page

By Format

View page

Molecular Diagnostics

Page

By-Laws

View page

About Diasorin

Shareholders' meeting

By-Laws (update April 22, 2021)

22/04/21 - 14:00

About Diasorin

Shareholders' meeting

By-Laws (updated at April 28, 2016)

28/04/16 - 14:00

About Diasorin

Events

CaixaBI & Banca Akros - Virtual Roadshow

12/11/2024

Portugal

Past event

Newsroom

Events

CaixaBI & Banca Akros - Virtual Roadshow

21/01/2022

Portugal

Past event

Newsroom

Events

CaixaBI & Banca Akros - Virtual Roadshow

31/03/2023

Portugal

Past event

Newsroom

Events

CaixaBI & Banca Akros - Virtual Roadshow

31/01/2024

Portugal

Past event

Newsroom

Page

Calendar

View page

Investors

Events

Calendar Corporate Events 2016

26/01/2016

Financial calendar

Past event

Newsroom

Press releases

Cardinal Health: agreement extended to 2014

06/10/11 - 2:00

Acquisition / Partnership

Investors

Page

Career

View page

Page

Careers

View page

Careers

Top management

Carlo Rosa

View page

About Diasorin

Image gallery

Carlo Rosa

Download (high) Download (low)

Top Management

Newsroom

Press releases

Change in share capital

24/11/10 - 1:00

Financial Data

Investors

Press releases

Change in share capital

30/09/10 - 2:00

Financial Data

Investors

Press releases

Change in share capital

02/11/10 - 1:00

Financial Data

Investors

Top management

Chen Even

View page

About Diasorin

Image gallery

Chen Even

Download (high) Download (low)

Top Management

Newsroom

Press releases

China approves new prenatal screening product line on LIAISON

09/04/10 - 2:00

Products Immunodiagnostic

Investors

Events

CIC Market Solutions Forum

19/05/2021

Past event

Newsroom

Events

Citi’s 2022 Virtual Healthcare Conference

23/02/2022

Past event

Newsroom

Press releases

Clostridium difficile on LIAISON (available outside the US and Canada only)

07/02/13 - 1:00

Products Immunodiagnostic

Investors

Press releases

Clostridium Difficile toxins A and B in stool on LIAISON (available outside the US and Canada only)

19/12/11 - 1:00

Products Immunodiagnostic

Investors

Page

Code of Ethics and Model 231

View page

About Diasorin

Press releases

Comment on position Paper on Vitamin D

02/12/10 - 1:00

Products Immunodiagnostic

Investors

Financial calendar

Communication of total amount of voting rights (7 June 2023)

07/06/23 - 14:00

About Diasorin

Press releases

Communication of total amount of voting rights (7 June 2023)

07/06/23 - 14:40

Financial Disclosures

Investors

Press releases

Communication on total amount of voting rights

07/08/18 - 8:45

Financial Data

Investors

Press releases

Communication on total amount of voting rights

07/03/19 - 11:45

Other

Investors

Press releases

Communication on total amount of voting rights

05/04/19 - 9:33

Other

Investors

Press releases

Communication on total amount of voting rights

12/04/19 - 8:59

Other

Investors

Press releases

Communication on total amount of voting rights

07/10/19 - 10:20

Other

Investors

Press releases

Communication on total amount of voting rights

16/04/24 - 8:20

Other

Investors

Press releases

Communication on total amount of voting rights

07/12/20 - 10:35

Other

Investors

Press releases

Communication on total amount of voting rights

07/06/21 - 15:16

Other

Investors

Press releases

Communication on total amount of voting rights

06/12/19 - 18:08

Other

Investors

Press releases

Communication on total amount of voting rights

07/02/20 - 8:06

Other

Investors

Press releases

Communication on total amount of voting rights (February 7, 2019)

07/02/19 - 15:15

Other

Investors

Press releases

Communication total amount voting rights (record date)

02/06/20 - 14:58

Investors

Shareholders' meeting

Communication total amount voting rights (record date)

10/06/20 - 14:00

About Diasorin

Buy back program

Communication voting rights amount

07/12/20 - 13:00

About Diasorin

Press releases

Communication voting rights amount

14/04/21 - 10:05

Other

Investors

Page

Company

View page

About Diasorin

Presentation

Company Presentation

26/06/15

Investors

Press releases

Compensation Commitee-Errata corrige

02/05/13 - 2:00

Financial Data

Investors

Shareholders' meeting

Compensation Report

22/04/13 - 14:00

About Diasorin

Shareholders' meeting

Compensation Report

23/04/14 - 14:00

About Diasorin

Shareholders' meeting

Compensation Report

22/04/15 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2011

22/03/12 - 13:00

About Diasorin

Shareholders' meeting

Compensation Report 2011

23/04/12 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2012

31/03/13 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2013

01/04/14 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2014

30/03/15 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2015

07/04/16 - 14:00

About Diasorin

Shareholders' meeting

Compensation Report 2015

28/04/16 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2016

05/04/17 - 14:00

About Diasorin

Shareholders' meeting

Compensation Report 2016

27/04/17 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2017

30/03/18 - 14:00

About Diasorin

Shareholders' meeting

Compensation Report 2017

23/04/18 - 14:00

About Diasorin

Reports on remuneration

Compensation Report 2018

02/04/19 - 14:00

About Diasorin

Shareholders' meeting

Compensation Report 2018

24/04/19 - 14:00

About Diasorin

Internal dealing operations

Comunicato Internal Dealing

20/09/24 - 14:00

About Diasorin

Internal dealing operations

Comunicato per Internal Dealing

24/03/14 - 13:00

About Diasorin

Buy back program

Conclusion buy-back plan

10/06/16 - 14:00

About Diasorin

Press releases

Conclusion buy-back plan

10/06/16 - 2:00

Financial Data

Investors

Buy back program

Conclusion treasury shares buy-back plan

04/07/18 - 14:00

About Diasorin

Buy back program

Conclusion treasury shares buy-back plan

23/10/20 - 14:00

About Diasorin

Buy back program

Conclusion treasury shares buy-back plan

02/11/21 - 13:00

About Diasorin

Buy back program

Conclusion treasury shares buy-back plan

19/04/18 - 14:00

About Diasorin

Press releases

Conclusion treasury shares buy-back plan

19/04/18 - 21:15

Financial Data

Investors

Press releases

Conclusion treasury shares buy-back plan

03/07/18 - 18:30

Financial Data

Investors

Press releases

Conclusion treasury shares buy-back plan

23/10/20 - 19:41

Other

Investors

Press releases

Conclusion treasury shares buy-back plan

02/11/21 - 20:00

Other

Investors

Events

Conference Call 1Q 2018 Results

02/05/2018

Corporate event

Past event

Newsroom

Events

Conference Call FY 2017 Results

27/02/2018

Corporate event

Past event

Newsroom

Events

Conference Call H1 2018 Results

13/07/2018

Corporate event

Past event

Newsroom

Page

Confirmation of registration

View page

Page

Confirmation of registration thank you

View page

Page

Contact us

View page

Press releases

Co-optation of a Director

19/12/16 - 10:00

Financial Data

Investors

Page

Corporate bodies

View page

About Diasorin

Shareholders' meeting

Corporate Governance

23/04/12 - 14:00

About Diasorin

Shareholders' meeting

Corporate Governance Report

19/07/10 - 14:00

About Diasorin

Reports on corporate governance

Corporate Governance Report 2009

09/04/10 - 14:00

About Diasorin

Reports on corporate governance

Corporate Governance Report 2010

06/04/11 - 14:00

About Diasorin

Reports on corporate governance

Corporate Governance Report 2011

30/03/12 - 14:00

About Diasorin

Press releases

Corporate Governance Report at December 2008.

10/04/09 - 2:00

Financial Data

Investors

Reports on corporate governance

Corporate Governance Report FY 2018

03/04/19 - 14:00

About Diasorin

Page

Coupling Accessories

View page

Luminex LTG

Page

Coverage

View page

Investors

Materiality issues

Customer satisfaction

View page

Sustainability

Press releases

CYTEK BIOSCIENCES TO ACQUIRE FLOW CYTOMETRY AND IMAGING BUSINESS FROM DIASORIN

13/02/23 - 22:03

Acquisition / Partnership

Investors

Presentation

DiaSorin - 9M 2022 Results Presentation

27/10/22

Investors

Press releases

DiaSorin - Annual General Meeting 2016

27/04/17 - 18:45

Financial Data

Investors

Press releases

DiaSorin - Cash flow generation and net profit hit record highs in 2019

11/03/20 - 13:43

Financial Data

Investors

Press releases

DiaSorin - Development of Coronavirus test

10/03/20 - 8:20

Products Molecular

Investors

Press releases

DiaSorin - FDA EUA and BARDA funding for SARS-CoV-2 IgG

25/04/20 - 16:49

Products Immunodiagnostic

Investors

Press releases

DiaSorin - launches the test for Brahms-Sepsis

29/04/15 - 2:00

Products Immunodiagnostic

Investors

Shareholders' meeting

DiaSorin : list of attendees

04/10/11 - 14:00

About Diasorin

Press releases

DiaSorin - Policlinico San Matteo Hospital in Pavia vs. Technogenetics

17/12/20 - 17:57

Other

Investors

Press releases

DiaSorin 2022-2025 Strategic Plan

Price sensitive

16/12/21 - 22:47

Financial Data

Investors

Press releases

DiaSorin and Beckman Coulter form strategic partnership to bring the LIAISON XL hepatitis and HIV products to the U.S. market

30/08/16 - 2:00

Acquisition / Partnership

Investors

Press releases

DiaSorin and Beckman Coulter sign a distribution agreement for China

20/07/15 - 2:00

Acquisition / Partnership

Investors

Press releases

DiaSorin and B·R·A·H·M·S, part of Thermo Fisher Scientific, partner to develop and commercialize the new LIAISON® B·R·A·H·M·S MR-proADM™

09/05/22 - 7:02

Acquisition / Partnership

Investors

Press releases

Diasorin and Gilead Sciences collaborate to develop a Fully Automated Diagnostic Assay for Hepatitis Delta Virus on Diasorin’s LIAISON XL® for the U.S. Market

06/11/23 - 15:44

Products Immunodiagnostic

Investors

Press releases

DiaSorin and Labcorp extend strategic business relationship

11/05/11 - 2:00

Acquisition / Partnership

Investors

Press releases

DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution

08/09/20 - 7:31

Acquisition / Partnership

Investors

Press releases

DiaSorin and Meridian enter into a strategic collaboration to sell Helicobacter pylori stool antigen test in the United States and in the United Kingdom

09/10/18 - 11:35

Acquisition / Partnership

Investors

Press releases

DiaSorin and QIAGEN collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease

05/06/19 - 7:38

Acquisition / Partnership Immunodiagnostic

Investors

Press releases

DiaSorin and QIAGEN sign collaboration to expand Liaison test menu through adoption of select QIAGEN assays

22/06/17 - 19:45

Acquisition / Partnership

Investors

Press releases

DiaSorin and TECAN to collaborate in new platform development

23/06/17 - 9:30

Acquisition / Partnership

Investors

Press releases

Diasorin announces 510(k) submission for LIAISON PLEX® Gram-Negative Blood Culture Assay

27/09/24 - 7:35

Products Molecular

Investors

Press releases

Diasorin Announces 510(k) Submission for LIAISON PLEX® Gram-Positive Blood Culture Assay, to complete the Blood Culture portfolio on LIAISON PLEX®

11/11/24 - 7:38

Products Molecular

Investors

Press releases

DiaSorin announces CE Marking of the new NxTAG® Gastrointestinal Molecular Multiplex Pathogen Panel

08/03/22 - 7:13

Products Molecular

Investors

Press releases

DiaSorin announces completion of the Acquisition of Luminex Corporation

14/07/21 - 15:05

Acquisition / Partnership

Investors

Press releases

DiaSorin announces its intention to offer € 500 million senior unsecured equity-linked bonds due 2028

28/04/21 - 7:54

Financial Data

Investors

Press releases

DiaSorin announces its intention to offer € 500 million senior unsecured equity-linked bonds due 2028

Price sensitive

28/04/21 - 7:54

Financial Data

Investors

Press releases

DiaSorin announces its strategic collaboration with Lumos Diagnostics

Price sensitive

06/04/21 - 7:06

Acquisition / Partnership

Investors

Press releases

Diasorin announces that it submitted the LIAISON® LymeDetect® to the U.S. Food and Drug Administration in December 2023

25/01/24 - 7:48

Products Immunodiagnostic

Investors

Press releases

DiaSorin announces the launch of its new CE marked LIAISON Testosterone xt test for the dosage of testosterone

06/08/20 - 7:25

Products Immunodiagnostic

Investors

Press releases

DiaSorin announces the launch of its new LIAISON® SARS-COV-2 IgM test, a new fully automated serology kit available in Europe and in the U.S. to identify the immediate response to SARS-COV-2 in COVID-19 patients

30/06/20 - 7:25

Products Immunodiagnostic

Investors

Image gallery

Diasorin at work

Download (high) Download (low)

Research laboratory

Newsroom

Image gallery

Diasorin at work

Download (high) Download (low)

Research laboratory

Newsroom

Press releases

DiaSorin became a member of the ISBT

17/02/12 - 1:00

Acquisition / Partnership

Investors

Press releases

Diasorin Board of Directors approves 2024-2027 Business Plan

Price sensitive

15/12/23 - 17:38

Financial Data

Investors

Press releases

DiaSorin Board of Directors approves first half 2019 results. Growth in revenues and profitability.

31/07/19 - 13:00

Financial Data

Investors

Press releases

DiaSorin business momentum and the Luminex acquisition drive Revenues and Profitability up in the first 9 months of 2021

Price sensitive

11/11/21 - 16:56

Financial Data

Investors

Press releases

DiaSorin business momentum and the Luminex acquisition drive up revenues, net result and cash flow generation in 2021

Price sensitive

16/03/22 - 17:39

Financial Data

Investors

Press releases

DiaSorin CE Marks its new Simplexa™ COVID-19 & Flu A/B Direct Assay for Detection and Differentiation of SARS-CoV-2 and Influenza in One Test

Price sensitive

18/09/21 - 8:16

Products Molecular

Investors

Press releases

DiaSorin CE Marks their ARIES® Flu A/B & RSV+SARS-CoV-2 Lowplex Assay

Price sensitive

20/05/22 - 7:08

Products Molecular

Investors

Press releases

DiaSorin CE marks their new Simplexa Flu A/B & RSV Direct Gen II Assay to run with the Simplexa COVID-19 Direct assay

07/07/20 - 7:22

Products Molecular

Investors

Press releases

DiaSorin commercializes molecular reagent for monkeypox virus

07/11/22 - 7:12

Products Molecular

Investors

Press releases

DiaSorin completes the acquisition of the ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS

29/09/17 - 14:15

Acquisition / Partnership

Investors

Press releases

DiaSorin confirms effectiveness of its Molecular Diagnostic tests in light of new Omicron SARS-CoV-2 Variant

30/11/21 - 19:10

Products Molecular

Investors

Press releases

DIASORIN CONFIRMS ITS ELIGIBILITY FOR THE PEA-PME

22/07/14 - 2:00

Financial Data

Investors

Press releases

DIASORIN CONSOLIDATES STRATEGIC PARTNERSHIP WITH MEMED BY SIGNING AN AGREEMENT TO DISTRIBUTE MEMED BV® TEST FOR THE ITALIAN MARKET ON THE MEMED KEY® POINT-OF-NEED PLATFORM

26/05/23 - 7:10

Acquisition / Partnership

Investors

Press releases

DiaSorin COVID-19 test has received FDA Emergency Use Authorization

20/03/20 - 7:28

Products Molecular

Investors

Sustainability projects

Diasorin Cup

View page

Sustainability

Press releases

DiaSorin earned CE-mark extending sample claims for DiaSorin Molecular's Simplexa HSV 1 & 2 kit

21/09/17 - 12:45

Products Molecular

Investors

Press releases

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test

28/03/18 - 18:45

Products Molecular

Investors

Press releases

DiaSorin extends its current joint venture with the Chinese Government to open a new manufacturing and research site in China

23/09/20 - 7:16

Acquisition / Partnership

Investors

Press releases

DiaSorin extends its master agreement with Laboratory Corporation of America Holdings till 2018

28/01/14 - 1:00

Acquisition / Partnership

Investors

Sustainability projects

Diasorin for Ukraine

View page

Sustainability

Press releases

DiaSorin furthers its collaboration with BARDA for the LIAISON® NES

05/10/22 - 6:37

Products Molecular

Investors

Press releases

DiaSorin: FY 2017 Results

07/03/18 - 15:30

Financial Data

Investors

Page

Diasorin Global Privacy Policy

View page

Legal information

Video gallery

Diasorin Group

Watch the video

Group

Newsroom

Press releases

DIASORIN GROUP REPORTS CONTINUED GROWTH IN REVENUES AND PROFITABILITY IN THE THIRD QUARTER 2016

10/11/16 - 1:00

Financial Data

Investors

Press releases

DiaSorin Group reports growth in profitability and strong free cash flow generation in the first quarter 2019

09/05/19 - 13:14

Financial Data

Investors

Press releases

DiaSorin Group reports growth in revenues and net profit in the first nine months of 2018

07/11/18 - 13:00

Financial Data

Investors

Press releases

DiaSorin Group reports growth in revenues and profitability in the first quarter 2017, generating a relevant cash flow

08/05/17 - 19:30

Financial Data

Investors

Press releases

DiaSorin Group reports revenue growth and confirmed profitability in the first quarter 2020 despite the impact of the pandemic

13/05/20 - 13:15

Financial Data

Investors

Press releases

DiaSorin Group reports strong growth in revenues and profitability in Q2 2017

03/08/17 - 14:45

Financial Data

Investors

Press releases

DiaSorin has CE marked its molecular's Simplexa™ Congenital CMV Direct Assay

12/06/20 - 7:30

Products Molecular

Investors

Press releases

DiaSorin has CE marked its SARS-COV-2 IgG serology kit for COVID-19

17/04/20 - 18:25

Products Immunodiagnostic

Investors

Press releases

DiaSorin has obtained FDA Emergency Use Authorization for its LIAISON® SARS-CoV-2 Ag for COVID-19 testing in the U.S.

Price sensitive

29/03/21 - 7:02

Products Immunodiagnostic

Investors

Press releases

DiaSorin has received BARDA Funding in support of submitting the SIMPLEXA COVID-19 Direct Kit for 510(k) clearance

29/12/20 - 18:22

Products Molecular

Investors

Press releases

DiaSorin in aid of Haiti's children in partnership with the Francesca Rava Foundation

24/03/15 - 1:00

Investors

Press releases

DiaSorin in India: JV with Trivitron Healthcare

30/07/12 - 2:00

Acquisition / Partnership

Investors

Press releases

DiaSorin, in partnership with QIAGEN, launches the new LIAISON® LymeDetect® Assay based on QuantiFERON technology

21/04/21 - 7:02

Products Immunodiagnostic

Investors

Press releases

DiaSorin increases diagnostic test menu for molecular screening of Acute Myeloid Leukemia

14/07/16 - 2:00

Products Molecular

Investors

Press releases

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia

12/06/18 - 14:15

Products Molecular

Investors

Presentation

DiaSorin Investor Day 2021 Presentation

17/12/21

Investors

Presentation

Diasorin Investor Day 2023 Presentation

15/12/23

Investors

Press releases

DiaSorin: launch of the LIAISON® Quick Detect COVID Ag assay, an antigen test to detect COVID-19 infection

Price sensitive

25/05/21 - 7:03

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches 3 new primer pairs for use in molecular testing

21/12/18 - 11:30

Products Molecular

Investors

Press releases

DiaSorin launches 3 new primer pairs for use in molecular testing: PNEUMOCYSTIS JIROVECII, GROUP C STREPTOCOCCUS, and GROUP G STREPTOCOCCUS

28/07/17 - 14:45

Products Molecular

Investors

Press releases

DiaSorin launches a new SIMPLEXA BORDETELLA DIRECT molecular test

12/12/17 - 13:15

Products Molecular

Investors

Press releases

DiaSorin launches ELASTASE-1 test for the diagnosis of chronic exocrine pancreatitis on LIAISON XL

06/05/19 - 15:19

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches FDA-cleared LIAISON Calprotectin test in the US market

31/01/19 - 22:30

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform

27/07/18 - 12:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches IAM CBFB-MYH11, completing the diagnostic test menu for molecular screening of acute myeloid leukemia by Q-LAMP

10/07/17 - 13:30

Products Molecular

Investors

Press releases

DIASORIN LAUNCHES ITS FIRST MOLECULAR TEST WITH THE NEW BUSINESS DIVISION, DIASORIN MOLECULAR: THE NEW SIMPLEXA C. DIFFICILE DIRECT MOLECULAR TEST

02/11/16 - 1:00

Products Molecular

Investors

Press releases

DiaSorin launches its first onco-hematology test on LIAISON Iam: the BCR-ABL

09/12/14 - 1:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches its new Simplexa C. Difficile direct molecular test in the US market

21/02/17 - 11:30

Products Molecular

Investors

Press releases

DIASORIN LAUNCHES LIAISON HCV TEST FOR HEPATITIS C DIAGNOSIS IN THE US MARKET

22/10/19 - 14:10

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches LIAISON® MeMed BV®, the first high throughput blood test to differentiate between bacterial and viral infections, in countries accepting the CE Mark

23/11/21 - 7:10

Products Immunodiagnostic

Investors

Press releases

DIASORIN LAUNCHES LIAISON® XL ZIKA CAPTURE IgM II TEST FOR THE DETECTION OF ZIKA VIRUS IN THE US MARKET

30/10/19 - 9:55

Products Immunodiagnostic

Investors

Press releases

DIASORIN LAUNCHES PRIMER PAIR FOR CANDIDA AURIS IN THE US MARKET

11/11/19 - 9:46

Products Molecular

Investors

Press releases

DiaSorin launches Simplexa Bordetella Direct Molecular test in the United States

03/01/19 - 13:30

Products Molecular

Investors

Press releases

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market

17/10/18 - 11:51

Products Molecular

Investors

Press releases

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States

19/11/18 - 15:00

Products Molecular

Investors

Press releases

DiaSorin launches Simplexa VZV Direct molecular assay in the european market

12/10/18 - 11:47

Products Molecular

Investors

Press releases

DiaSorin launches the anaemia panel on Liaison XL in Europe

03/04/19 - 10:32

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the EHEC Toxins test on stool samples

25/10/13 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the first fully automated CLIA high-throughput solution for diagnosing Hepatitis E

15/06/21 - 6:56

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the hCG test on its LIAISON XL in the US

24/09/13 - 2:00

Products Immunodiagnostic

Investors

Press releases

DIASORIN LAUNCHES THE LIAISON FGF 23 TEST, THE FIRST INNOVATIVE AND FULLY AUTOMATED MARKER FOR CHRONIC KIDNEY DISEASE

26/01/17 - 12:45

Products Immunodiagnostic

Investors

Press releases

DIASORIN LAUNCHES THE LIAISON QUANTIFERON-TB GOLD PLUS ASSAY IN PARTNERSHIP WITH QIAGEN IN THE US MARKET

27/11/19 - 7:59

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the LIAISON® B·R·A·H·M·S MR-proADM™ assay in all countries accepting the CE Mark

13/06/23 - 15:18

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the LIAISON® IQ with a first test that detects IgG antibodies against SARS-COV-2 in markets accepting the CE Mark

Price sensitive

20/04/21 - 18:58

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease

17/07/23 - 7:03

Products Immunodiagnostic

Investors

Press releases

Diasorin launches the LIAISON® Streptococcus pneumoniae Ag Assay in all countries accepting the CE Mark

09/09/24 - 13:11

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the new Helicobacter pylori IgG CLIA test

07/06/16 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the new Liaison Androstenedione test for the evaluation of adrenal and gonadal functionality

16/05/17 - 13:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the new Liaison SHBG test for the diagnosis of androgen-related disorders

23/05/17 - 11:45

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen

17/09/18 - 11:28

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the new test for Parvovirus on LIAISON IAM

20/06/13 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the new test for PTH on LIAISON

18/02/14 - 1:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM

24/07/13 - 2:00

Products

Investors

Press releases

DiaSorin launches the stool test for Adenovirus on LIAISON

18/09/14 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for Calprotectin

14/01/15 - 1:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for Campylobacter

28/05/15 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for Cytomegalovirus on LIAISON IAM

09/01/14 - 1:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for Herpes Simplex 1 and 2 on LIAISON IAM

30/06/14 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for HIV HT on LIAISON

07/10/14 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for IgG to Trypanosoma Cruzi (Chagas)

10/10/13 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for Rotavirus on stool sample

11/02/14 - 1:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test for Vitamin D 1,25 on LIAISON

03/06/14 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the test of Chlamydia Trachomatis IgG and IgA on LIAISON

28/06/13 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the tests for Bordetella pertussis

14/04/15 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches the two fastest molecular diagnostic tests in the world to detect fulminant leukemias

09/09/15 - 2:00

Products Molecular

Investors

Press releases

DiaSorin launches VZV Direct molecular test in Europe

24/09/19 - 10:10

Products Molecular

Investors

Press releases

DiaSorin launches VZV DIRECT molecular test in the United States

29/05/19 - 15:06

Products Molecular

Investors

Press releases

DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients

26/10/20 - 18:30

Products Immunodiagnostic

Investors

Press releases

DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 TrimericS IgG test

11/01/21 - 18:43

Products Immunodiagnostic

Investors

Press releases

DiaSorin obtained FDA approval for two additional serology tests for Lyme Disease in the U.S. market

23/02/21 - 6:11

Products Immunodiagnostic

Investors

Press releases

DiaSorin obtains all approvals necessary to complete the acquisition of Luminex

09/07/21 - 7:34

Acquisition / Partnership

Investors

Press releases

DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in Brazil

11/07/13 - 2:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in China

24/01/14 - 1:00

Products Immunodiagnostic

Investors

Press releases

DIASORIN PARTNERS WITH HHS TO FACE THE ZIKA EMERGENCY

22/08/16 - 2:00

Products Immunodiagnostic

Investors

Presentation

DiaSorin Presentation - Planned Acquisition of Focus Diagnostics Product Business

30/03/16

Investors

Press releases

DiaSorin presents its 2017-2019 Industrial Plan

26/06/17 - 9:45

Financial Data

Investors

Press releases

DiaSorin presents its 2019-2022 Industrial Plan

10/06/19 - 18:23

Financial Data

Investors

Press releases

DiaSorin presents the 2015-2017 industrial plan

12/05/15 - 2:00

Other

Investors

Press releases

Diasorin: Publication of the documents for the Ordinary Shareholders' Meeting scheduled on April 24, 2024

15/03/24 - 17:14

Other

Investors

Press releases

Diasorin: Publication of the documents for the Shareholders' Meeting scheduled on September 4, 2024

29/07/24 - 17:35

Other

Investors

Financial calendar

DiaSorin: Publication of the updated proxy forms for voting through the Designated Representative

13/04/22 - 14:00

About Diasorin

Press releases

DiaSorin: Publication of the updated proxy forms for voting through the Designated Representative

13/04/22 - 16:43

Financial Disclosures

Investors

Press releases

DIASORIN RAISES FULL-YEAR 2024 GUIDANCE AS A RESULT OF THE POSITIVE PERFORMANCE OF THE FIRST SEMESTER OF THE YEAR

Price sensitive

29/07/24 - 15:55

Financial Data

Investors

Press releases

DiaSorin received BARDA funding to develop a rapid COVID-19 test

13/03/20 - 17:16

Products Molecular

Investors

Press releases

DiaSorin received BARDA funding to develop and achieve FDA regulatory authorization, for its LIAISON® SARS-CoV-2 Ag test

30/03/21 - 7:01

Products Immunodiagnostic

Investors

Press releases

DiaSorin received FDA approval for its LIAISON® XL MUREX HIV Ab/Ag assay, completing the Hepatitis and Retrovirus offer in the US market

01/12/20 - 6:33

Products Immunodiagnostic

Investors

Press releases

DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market

01/10/20 - 7:45

Products Immunodiagnostic

Investors

Press releases

DiaSorin receives authorization for the distribution of Zika IgM test in Europe

21/04/17 - 18:45

Products Immunodiagnostic

Investors

Press releases

Diasorin receives FDA 510(K) clearance for its LIAISON PLEX® system together with the LIAISON PLEX® Respiratory Panel

Price sensitive

03/03/24 - 19:32

Products Molecular

Investors

Press releases

DiaSorin receives FDA 510(k) clearance for its LIAISON® MeMed BV® test

14/07/22 - 20:00

Products Immunodiagnostic

Investors

Press releases

Diasorin receives FDA 510(k) clearance for the LIAISON PLEX® Blood Culture Yeast Assay on the new multiplexing LIAISON PLEX®

05/06/24 - 5:07

Products Molecular

Investors

Press releases

Diasorin receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2

16/05/24 - 19:56

Products Molecular

Investors

Press releases

DiaSorin receives FDA approval for its LIAISON® QuantiFERON®-TB Gold Plus assay for use on the LIAISON® XS Analyzer

29/11/21 - 7:06

Products Immunodiagnostic

Investors

Press releases

Diasorin receives FDA clearance for Simplexa VZV Swab Direct Molecular assay

16/12/19 - 14:10

Products Molecular

Investors

Press releases

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis)

05/04/18 - 12:00

Products Immunodiagnostic

Investors

Press releases

Diasorin receives FDA de-novo grant for the SIMPLEXA® C. auris Direct assay on the LIAISON® MDX instrument

16/07/24 - 8:31

Products Molecular

Investors

Press releases

DiaSorin receives FDA Emergency Use Authorization for the first, fully - automated Zika IgM test

06/04/17 - 18:00

Products Immunodiagnostic

Investors

Press releases

DiaSorin Releases an Assay for Rapid Identification of Mutations Associated with Circulating Variants of SARS-CoV-2

Price sensitive

21/05/21 - 7:02

Products Molecular

Investors

Press releases

DiaSorin releases an updated Simplexa™ SARS-CoV-2 Variants Direct molecular assay (RUO) for the detection of mutations associated with the Omicron variant

Price sensitive

13/01/22 - 7:24

Products Molecular

Investors

Press releases

Diasorin reports another quarter with Revenues and Profitability in expansion, raising the Full-Year 2024 Revenue Guidance

Price sensitive

05/11/24 - 16:27

Financial Data

Investors

Press releases

DiaSorin: Revenues and Profitability continue upward momentum in the First Half of 2021, with Guidance raised following the acquisition of Luminex

Price sensitive

30/07/21 - 12:57

Financial Data

Investors

Press releases

DiaSorin revises its guidance upwards for 2019 as a consequence of the completion of the acquisition of ELISA immunodiagnostic business portfolio and associated assets from SIEMENS

29/09/17 - 15:00

Financial Data

Investors

Presentation

DiaSorin Roadshow Presentation - March 2018

15/03/18

Investors

Presentation

DiaSorin Roadshow Presentation - May 2018

17/05/18

Investors

Presentation

DiaSorin Roadshow Presentation - November 2018

12/11/18

Investors

Presentation

DiaSorin Roadshow Presentation - September 2018

31/08/18

Investors

Presentation

DiaSorin Roadshow Presentation - September 2022

13/09/22

Investors

Press releases

DiaSorin: Shareholders' Meeting 2019

24/04/19 - 17:24

Other

Investors

Press releases

DiaSorin signes a 5-year agreement with Roche

29/10/13 - 1:00

Acquisition / Partnership

Investors

Press releases

DiaSorin: significant growth in Revenues and Profitability in the first quarter 2021

Price sensitive

14/05/21 - 16:10

Financial Data

Investors

Press releases

DiaSorin signs agreements with Unifarma and Alliance Healthcare for the distribution in Italian pharmacies of the LIAISON® IQ

03/06/21 - 7:47

Acquisition / Partnership

Investors

Press releases

DiaSorin signs an agreement with Seegene

02/04/13 - 2:00

Acquisition / Partnership

Investors

Press releases

DiaSorin signs an agreement with the Italian Tax Authority granting tax relief under the Italian Patent Box regime

30/01/18 - 11:45

Financial Data

Investors

Press releases

DiaSorin signs an exclusive licensing agreement for molecular diagnostic POC technology

02/03/20 - 8:04

Acquisition / Partnership

Investors

Press releases

DiaSorin Simplexa COVID Flu assay received U.S. FDA 510(K) clearance

Price sensitive

17/03/23 - 22:05

Products Molecular

Investors

Press releases

DiaSorin Simplexa® cCMV Direct assay received U.S. FDA 510(K) clearance

09/11/22 - 7:04

Products Molecular

Investors

Press releases

DiaSorin Simplexa™ COVID-19 Direct molecular test CE marked for saliva specimens

16/09/20 - 7:25

Products Molecular

Investors

Press releases

DIASORIN SIMPLEXA™ COVID-19 TEST RECEIVED U.S. FDA 510(K) CLEARANCE

Price sensitive

14/09/22 - 0:29

Products Molecular

Investors

Press releases

Diasorin S.p.A. - Shareholders' Meeting September 4, 2024

04/09/24 - 11:36

Other

Investors

Buy back program

DiaSorin S.p.A. - Treasury shares buy back November 2024

09/12/24 - 13:00

About Diasorin

Press releases

DiaSorin S.p.A. - Update 2024 Annual Calendar of Corporate Events

05/09/24 - 11:17

Other

Investors

Shareholders' meeting

DiaSorin SpA: Shareholders' meeting Audit Report

19/07/10 - 14:00

About Diasorin

Shareholders' meeting

DiaSorin S.p.A., the ordinary shareholders' meeting apporves the 2010 statutory financial statements and the dividend distribution

28/04/11 - 14:00

About Diasorin

Press releases

DiaSorin S.p.A.- Update 2024 Annual Calendar of Corporate Events

04/04/24 - 9:34

Financial Disclosures , Other

Investors

Press releases

DiaSorin starts selling Vitamin D in Japan

28/07/16 - 2:00

Products Immunodiagnostic

Investors

Press releases

Diasorin submits LIAISON PLEX® Yeast Blood Culture Assay for the LIAISON PLEX® system to the U.S. FDA

13/03/24 - 10:23

Products Molecular

Investors

Press releases

DiaSorin successfully prices its offer of € 500 million Senior Unsecured Equity-Linked Bonds due 2028

28/04/21 - 17:46

Financial Data

Investors

Press releases

DiaSorin successfully prices its offer of € 500 million Senior Unsecured Equity-Linked Bonds due 2028

Price sensitive

28/04/21 - 17:46

Financial Data

Investors

Press releases

DiaSorin supports Emergency in Sudan

24/02/15 - 1:00

Investors

Press releases

DiaSorin supports the Pinocchio Project

23/04/15 - 2:00